Essex Bio-Technology Limited (HKG:1061)
Hong Kong
· Delayed Price · Currency is HKD 4.540
+0.140 (3.18%)
Apr 29, 2025, 4:08 PM HKT
Essex Bio-Technology Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 28, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 2,574 | 1,667 | 1,413 | 2,401 | 2,848 | 2,463 | Upgrade
|
| Market Cap Growth | 17.98% | 17.98% | -41.13% | -15.72% | 15.63% | -32.35% | Upgrade
|
| Enterprise Value | 2,201 | 1,394 | 1,349 | 2,272 | 2,753 | 2,432 | Upgrade
|
| Last Close Price | 4.54 | 2.94 | 2.38 | 3.93 | 4.53 | 3.84 | Upgrade
|
| PE Ratio | 8.54 | 5.43 | 5.13 | 10.65 | 8.23 | 11.25 | Upgrade
|
| Forward PE | 7.96 | 11.26 | 11.26 | 11.26 | 11.26 | 11.26 | Upgrade
|
| PS Ratio | 1.54 | 1.00 | 0.81 | 1.82 | 1.74 | 2.52 | Upgrade
|
| PB Ratio | 1.21 | 0.79 | 0.74 | 1.39 | 1.64 | 1.73 | Upgrade
|
| P/TBV Ratio | 2.17 | 1.41 | 1.36 | 2.73 | 2.64 | 2.61 | Upgrade
|
| P/FCF Ratio | 7.94 | 5.15 | 4.44 | 8.19 | 8.93 | 12.19 | Upgrade
|
| P/OCF Ratio | 6.99 | 4.53 | 4.17 | 6.27 | 6.96 | 8.23 | Upgrade
|
| EV/Sales Ratio | 1.32 | 0.84 | 0.78 | 1.72 | 1.68 | 2.49 | Upgrade
|
| EV/EBITDA Ratio | 5.47 | 3.48 | 3.35 | 6.76 | 6.57 | 8.88 | Upgrade
|
| EV/EBIT Ratio | 6.25 | 3.93 | 3.84 | 7.52 | 6.99 | 9.67 | Upgrade
|
| EV/FCF Ratio | 6.79 | 4.30 | 4.24 | 7.75 | 8.63 | 12.03 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.09 | 0.15 | 0.28 | 0.33 | 0.40 | Upgrade
|
| Debt / EBITDA Ratio | 0.46 | 0.46 | 0.72 | 1.45 | 1.34 | 2.04 | Upgrade
|
| Debt / FCF Ratio | 0.58 | 0.58 | 0.92 | 1.67 | 1.77 | 2.78 | Upgrade
|
| Asset Turnover | 0.57 | 0.57 | 0.63 | 0.47 | 0.62 | 0.44 | Upgrade
|
| Inventory Turnover | 2.14 | 2.14 | 2.07 | 1.34 | 1.83 | 1.32 | Upgrade
|
| Quick Ratio | 1.62 | 1.62 | 1.37 | 1.81 | 1.95 | 1.79 | Upgrade
|
| Current Ratio | 1.81 | 1.81 | 1.54 | 2.16 | 2.24 | 2.20 | Upgrade
|
| Return on Equity (ROE) | 15.18% | 15.18% | 15.06% | 13.01% | 21.89% | 16.69% | Upgrade
|
| Return on Assets (ROA) | 7.63% | 7.63% | 7.93% | 6.77% | 9.31% | 6.99% | Upgrade
|
| Return on Capital (ROIC) | 9.79% | 9.79% | 9.90% | 8.35% | 11.48% | 8.85% | Upgrade
|
| Return on Capital Employed (ROCE) | 15.60% | 15.60% | 17.40% | 14.00% | 18.10% | 13.90% | Upgrade
|
| Earnings Yield | 11.93% | 18.43% | 19.48% | 9.39% | 12.15% | 8.89% | Upgrade
|
| FCF Yield | 12.59% | 19.44% | 22.51% | 12.22% | 11.20% | 8.21% | Upgrade
|
| Dividend Yield | 2.73% | 4.08% | 3.78% | 1.65% | 2.10% | 1.30% | Upgrade
|
| Payout Ratio | 19.39% | 19.39% | 14.50% | 24.19% | 15.00% | 13.20% | Upgrade
|
| Buyback Yield / Dilution | 2.24% | 2.24% | 0.62% | 0.43% | 0.21% | 0.12% | Upgrade
|
| Total Shareholder Return | 4.96% | 6.32% | 4.40% | 2.09% | 2.31% | 1.42% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.